Gram-negative blood culture assay to ID and treat sepsis, 10/13

Create PDF

AdvanDx, a provider of molecular diagnostic tests for identifying pathogens that cause critical infections in hospitalized patients, announced the commercial launch of Gram-Negative QuickFISH BC, the third FDA-cleared test in its QuickFISH blood culture pathogen identification platform.

Gram-Negative QuickFISH BC is a rapid molecular diagnostic test that identifies bloodstream infections caused by Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae within 20 minutes of a positive blood culture.